A Study of JNJ-64140284 in Healthy Male Participants
Clinical trial NCT04566926 · TERMINATED
Trial details
- NCT number
- NCT04566926
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2021-04-05
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.